Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02453763 · ClinicalTrials.gov registry record

In Vivo Imaging of Therapeutic Electric Current Flow

A clinical trial of Depression and Stroke, sponsored by University of Florida.

Completed
Registry status
17
Enrollment target
1
Study location

NCT02453763: Completed study of Depression and Stroke, sponsored by University of Florida.

NCT02453763 is a study of Depression and Stroke that has completed, run by University of Florida. The registered enrollment target is 17 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02453763, a study of Depression and Stroke, has completed, sponsored by University of Florida.

COMPLETED
Registry status
17 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to measure current flow inside the head using magnetic resonance imaging (MRI). The data from this study will be used to map the current flow caused from the electrical stimulation inside the head. The methods develop will be used to map and better control delivery of the current for electrical stimulation to modify a psychiatric condition such as depression; or other conditions such as epilepsy, Parkinson's disease or autism.

Primary Outcome

The MRI will be used to measure current flow in the brain as a result of therapeutic electrical stimulation techniques by using a recently developed MRI-based phase imaging technique to more directly measure current densities in vivo.

Interventions

  • DEVICE Transcranial direct current stimulation
  • PROCEDURE MRI

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2015-06
Est. Completion 2017-07-06
University of Florida

1,106 total trials

What the finished NCT02453763 record still lists

NCT02453763 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower).

The record links to 7 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Transcranial direct current stimulation is the first listed.

NCT02453763 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT02453763 about?

NCT02453763 is a clinical study titled "In Vivo Imaging of Therapeutic Electric Current Flow". The purpose of this research study is to measure current flow inside the head using magnetic resonance imaging (MRI). The data from this study will be used to map the current flow caused from the electrical stimulation inside the head. The methods develop will be used to map and better control deliv...

What is the current status of trial NCT02453763?

This trial is currently completed. The enrollment target is 17 participants. The study started on 2015-06. Estimated completion is 2017-07-06.

What conditions does trial NCT02453763 study?

This clinical trial studies the following conditions: Depression, Stroke, Schizophrenia, Parkinson Disease, Epilepsy.

What interventions are being tested in trial NCT02453763?

The interventions under investigation include: Transcranial direct current stimulation (DEVICE), MRI (PROCEDURE).

Who is sponsoring clinical trial NCT02453763?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02453763 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02453763's enrollment target sits among peer trials

17 631st of 679 higher than 46 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02453763, the US trial registry maintained by the National Library of Medicine. NCT02453763 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.